Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp Block vs IV Parecoxib for Post-Cranioplasty Pain
NCT05442411Phase 1Completed
- Sponsor
- Universiti Sains Malaysia
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoint: Visual Analogue Scale (VAS) Pain Score at 12 hours. Started Mar 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05442411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05442411.